新生血管-话题@MedSci

#新生血管#

25篇内容 | 1502人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1703987, encodeId=41001e0398738, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Front Cardiovasc Med：鳖甲软脉汤通过诱导视网膜血管内皮细胞凋亡抑制糖尿病小鼠视网膜新生血管形成, objectType=article, longId=735824, objectId=344be3582470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=344be3582470, replyNumber=0, likeNumber=147, createdTime=2023-05-11, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=344be3582470, moduleTitle=Front Cardiovasc Med：鳖甲软脉汤通过诱导视网膜血管内皮细胞凋亡抑制糖尿病小鼠视网膜新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=344be3582470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703985, encodeId=a88d1e0398570, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, objectType=article, longId=294903, objectId=5c2c29490389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c2c29490389, replyNumber=0, likeNumber=94, createdTime=2022-12-21, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c2c29490389, moduleTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c2c29490389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703986, encodeId=10301e03986c8, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=化疗和放疗对乳房重建中脱细胞真皮基质的炎症反应、新生血管形成和包膜形成的影响, objectType=article, longId=300242, objectId=7aa030024203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa030024203, replyNumber=0, likeNumber=75, createdTime=2022-03-28, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa030024203, moduleTitle=化疗和放疗对乳房重建中脱细胞真皮基质的炎症反应、新生血管形成和包膜形成的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa030024203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703984, encodeId=703b1e03984ee, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, objectType=article, longId=215112, objectId=292a21511215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=292a21511215, replyNumber=0, likeNumber=74, createdTime=2022-07-02, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=292a21511215, moduleTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=292a21511215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703982, encodeId=df0d1e03982fc, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=JAMA Ophthalmol：阿帕西普 VS 全视网膜光凝术（PRP）——增殖性糖尿病患者视网膜新生血管的治疗比较, objectType=article, longId=208312, objectId=6cf9208312fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf9208312fb, replyNumber=0, likeNumber=73, createdTime=2022-02-10, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf9208312fb, moduleTitle=JAMA Ophthalmol：阿帕西普 VS 全视网膜光凝术（PRP）——增殖性糖尿病患者视网膜新生血管的治疗比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf9208312fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703983, encodeId=595c1e0398392, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=JNNP：烟雾病间接血运重建术后新生血管生成的预测因素：一项10年随访研究, objectType=article, longId=209872, objectId=3bf52098e2ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf52098e2ff, replyNumber=0, likeNumber=91, createdTime=2021-04-22, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf52098e2ff, moduleTitle=JNNP：烟雾病间接血运重建术后新生血管生成的预测因素：一项10年随访研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bf52098e2ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703978, encodeId=8b2f1e039787b, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Medicine (Baltimore)：新生血管性青光眼治疗策略的分析, objectType=article, longId=164524, objectId=6049164524e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6049164524e8, replyNumber=0, likeNumber=78, createdTime=2020-03-19, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6049164524e8, moduleTitle=Medicine (Baltimore)：新生血管性青光眼治疗策略的分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6049164524e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703980, encodeId=1fe21e039809a, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=SciRep：光学相干断层扫描血管造影诊断慢性中心浆液性脉络膜视网膜病变中脉络膜新生血管情况, objectType=article, longId=174472, objectId=ab221e447276, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab221e447276, replyNumber=0, likeNumber=76, createdTime=2019-07-19, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab221e447276, moduleTitle=SciRep：光学相干断层扫描血管造影诊断慢性中心浆液性脉络膜视网膜病变中脉络膜新生血管情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab221e447276)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703981, encodeId=63761e0398180, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=中国新生血管性青光眼诊疗专家共识（2019年）, objectType=article, longId=184279, objectId=c5c91842e9d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5c91842e9d2, replyNumber=0, likeNumber=70, createdTime=2020-02-26, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5c91842e9d2, moduleTitle=中国新生血管性青光眼诊疗专家共识（2019年）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5c91842e9d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703979, encodeId=70a21e0397968, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Exp Eye Res：负载贝伐单抗的白蛋白纳米颗粒在治疗角膜新生血管中的体内研究, objectType=article, longId=172192, objectId=47fd1e21929a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47fd1e21929a, replyNumber=0, likeNumber=77, createdTime=2020-04-28, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47fd1e21929a, moduleTitle=Exp Eye Res：负载贝伐单抗的白蛋白纳米颗粒在治疗角膜新生血管中的体内研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47fd1e21929a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703976, encodeId=22631e0397606, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响, objectType=article, longId=161454, objectId=bba5161454b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba5161454b9, replyNumber=0, likeNumber=77, createdTime=2019-07-24, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba5161454b9, moduleTitle=Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba5161454b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703977, encodeId=b1251e0397718, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Blood：VWF的肝素结合结构域可结合生长因子促进新生血管形成, objectType=article, longId=164241, objectId=807c164241ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=807c164241ae, replyNumber=0, likeNumber=90, createdTime=2019-04-26, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=807c164241ae, moduleTitle=Blood：VWF的肝素结合结构域可结合生长因子促进新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=807c164241ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703974, encodeId=c7db1e039742f, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成, objectType=article, longId=147575, objectId=19e114e57567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e114e57567, replyNumber=0, likeNumber=64, createdTime=2019-06-11, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e114e57567, moduleTitle=Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e114e57567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703975, encodeId=e7cb1e03975d8, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较, objectType=article, longId=149444, objectId=ee5e149444ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5e149444ff, replyNumber=0, likeNumber=68, createdTime=2018-10-26, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5e149444ff, moduleTitle=Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5e149444ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703972, encodeId=ad7c1e03972df, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Retina：在中国实际生活中治疗新生血管性年龄相关黄斑变性, objectType=article, longId=132834, objectId=5a541328347b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a541328347b, replyNumber=0, likeNumber=73, createdTime=2018-12-27, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a541328347b, moduleTitle=Retina：在中国实际生活中治疗新生血管性年龄相关黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a541328347b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703970, encodeId=6dac1e03970e3, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Biomed Pharmacother：特立帕肽可促进新生血管形成, objectType=article, longId=122537, objectId=237412253e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=237412253e9e, replyNumber=0, likeNumber=61, createdTime=2017-12-24, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=237412253e9e, moduleTitle=Biomed Pharmacother：特立帕肽可促进新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=237412253e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703973, encodeId=929a1e0397319, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=Ophthalmic Plast Reconstr Surg：强脉冲光损伤导致脉络膜新生血管形成, objectType=article, longId=140772, objectId=a032140e729a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a032140e729a, replyNumber=0, likeNumber=79, createdTime=2018-08-10, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a032140e729a, moduleTitle=Ophthalmic Plast Reconstr Surg：强脉冲光损伤导致脉络膜新生血管形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a032140e729a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703969, encodeId=684a1e0396940, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=J Ocul Pharmacol Ther：新生血管性年龄相关黄斑变性中病变活动的形态学标准！, objectType=article, longId=122233, objectId=15de12223302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15de12223302, replyNumber=0, likeNumber=92, createdTime=2018-09-08, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15de12223302, moduleTitle=J Ocul Pharmacol Ther：新生血管性年龄相关黄斑变性中病变活动的形态学标准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15de12223302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703971, encodeId=be991e039711e, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性, objectType=article, longId=123712, objectId=68b0123e1227, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b0123e1227, replyNumber=0, likeNumber=76, createdTime=2018-09-24, rootId=0, userName=chenzhuanggui, userId=d68830606495, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b0123e1227, moduleTitle=2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b0123e1227)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1703968, encodeId=bf9d1e03968db, content=<a href='/topic/show?id=64e05854824' target=_blank style='color:#2F92EE;'>#新生血管#</a>, objectTitle=第5个适应症！罗氏眼科药物Lucentis（雷珠单抗）获美国FDA批准治疗近视性脉络膜新生血管（mCNV）, objectType=article, longId=86943, objectId=563e86943ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=563e86943ab, replyNumber=0, likeNumber=76, createdTime=2017-03-27, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=563e86943ab, moduleTitle=第5个适应症！罗氏眼科药物Lucentis（雷珠单抗）获美国FDA批准治疗近视性脉络膜新生血管（mCNV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=563e86943ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新生血管

2020-05-29

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Front Cardiovasc Med：鳖甲软脉汤通过诱导视网膜血管内皮细胞凋亡抑制糖尿病小鼠视网膜新生血管形成

2023-05-11

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果

2022-12-21

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

化疗和放疗对乳房重建中脱细胞真皮基质的炎症反应、新生血管形成和包膜形成的影响

2022-03-28

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病

2022-07-02

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

JAMA Ophthalmol：阿帕西普 VS 全视网膜光凝术（PRP）——增殖性糖尿病患者视网膜新生血管的治疗比较

2022-02-10

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

JNNP：烟雾病间接血运重建术后新生血管生成的预测因素：一项10年随访研究

2021-04-22

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Medicine (Baltimore)：新生血管性青光眼治疗策略的分析

2020-03-19

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

SciRep：光学相干断层扫描血管造影诊断慢性中心浆液性脉络膜视网膜病变中脉络膜新生血管情况

2019-07-19

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

中国新生血管性青光眼诊疗专家共识（2019年）

2020-02-26

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Exp Eye Res：负载贝伐单抗的白蛋白纳米颗粒在治疗角膜新生血管中的体内研究

2020-04-28

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响

2019-07-24

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Blood：VWF的肝素结合结构域可结合生长因子促进新生血管形成

2019-04-26

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Med Sci Monit：ATN-161作为整合素α5β1拮抗剂通过促进新生血管内皮细胞凋亡抑制眼部新生血管形成

2019-06-11

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较

2018-10-26

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Retina：在中国实际生活中治疗新生血管性年龄相关黄斑变性

2018-12-27

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Biomed Pharmacother：特立帕肽可促进新生血管形成

2017-12-24

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

Ophthalmic Plast Reconstr Surg：强脉冲光损伤导致脉络膜新生血管形成

2018-08-10

智者为医08 (审核中...)

前往app查看评论内容

#新生血管#

J Ocul Pharmacol Ther：新生血管性年龄相关黄斑变性中病变活动的形态学标准！

2018-09-08

chenzhuanggui (审核中...)

前往app查看评论内容

#新生血管#

2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性

2018-09-24

智者为医08 (审核中...)

前往app查看评论内容

#新生血管#

第5个适应症！罗氏眼科药物Lucentis（雷珠单抗）获美国FDA批准治疗近视性脉络膜新生血管（mCNV）

2017-03-27

科室
- - 订阅+
  - 更多科室
工具
服务